GlassScriptPhysician profile
Osbel Borges
NPI 1518213388
$2,121.19
in general payments reported to CMS, 2019-2025
24 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $137 · 2021: $182 · 2022: $219 · 2023: $368 · 2024: $432 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $325.31 | 2023-2025 | |
| Stryker Corporation | $217.67 | 2021-2025 | Na, Smartlock |
| Straumann USA LLC | $216.06 | 2019-2025 | |
| Zimvie INC. | $176.82 | 2023 | |
| Integra Lifesciences Corporation | $157.38 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nobel Biocare USA | $143.05 | 2022-2023 | Nobelactive |
| Melinta Therapeutics, LLC | $137.78 | 2019 | |
| Mentor Worldwide LLC | $119.54 | 2019 | |
| Keystone Dental INC. | $107.71 | 2019 | |
| Kerecis Limited | $79.54 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Regeneron Healthcare Solutions, INC. | $63.58 | 2024 | Libtayo |
| Envista Holdings Corporation | $62.58 | 2024-2025 | Maxcem Elite, Endodontics |
| Sientra, INC. | $49.87 | 2020 | |
| Tela Bio, INC. | $48.64 | 2021 | |
| Dentsply Sirona INC | $36.25 | 2020-2023 | Astra Tech Implant System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $33.68 | 2020-2021 | |
| Kulzer, LLC | $28.60 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $22.23 | 2022 | |
| Avita Medical Americas, LLC | $21.30 | 2024 | |
| Molnlycke Health Care US, LLC | $17.57 | 2023 | Avance, Mepilex Border Ag |
| Depuy Synthes Sales INC. | $16.01 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $14.37 | 2025 | |
| Amniox Medical, INC. | $13.22 | 2019 | |
| Checkpoint Surgical, INC | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osbel Borges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.